Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
Clinical trial NCT03463031 · COMPLETED
Trial details
- NCT number
- NCT03463031
- Sponsor
- Glenmark Specialty S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2018-11-14
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.